EP Patent

EP0307804A2 — Cephem compound and a process for preparation thereof

Assigned to Fujisawa Pharmaceutical Co Ltd · Expires 1989-03-22 · 37y expired

What this patent protects

A cephem compound of the formula : wherein R 1 is amino or a protected amino, R 2 is lower alkyl which may have one or more suitable substituent(s), R 3 is COO e , carboxy or a protected carboxy, R 4 is hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R…

USPTO Abstract

A cephem compound of the formula : wherein R 1 is amino or a protected amino, R 2 is lower alkyl which may have one or more suitable substituent(s), R 3 is COO e , carboxy or a protected carboxy, R 4 is hydroxy(lower)alkyl or protected hydroxy(lower)alkyl, R 5 is amino or a protected amino, R 6 is hydrogen or lower alkyl, X 9 is an anion, and n is 0 or 1, with proviso that (i) when R 3 is COO e , then n is 0, and (ii) when R 3 is carboxy or a protected carboxy, then n is 1, and pharmaceutically acceptable salt thereof, processes for their preparation and pharmaceutical compositions comprising them as active ingredient in admixture with pharmaceutically acceptable carriers.

Drugs covered by this patent

Patent Metadata

Patent number
EP0307804A2
Jurisdiction
EP
Classification
Expires
1989-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Fujisawa Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.